Bio Path | BPTH - Fremdkapital





Fremdkapital Veränderung Datum
Alterity Therapeutics Limited AUD 43.68K 59.53K 2025-12
Baxter International USD 8.62B 6M 2026-06
Bio Path USD 0 0 2025-03
Cipla INR 3.82B 840.2M 2026-03
Clal Biotechnology ILS 25.96M 18.48M 2023-12
Compugen USD 0 0 2024-12
CSL USD 10.42B 273M 2025-12
Grifols EUR 9.95B 722.93M 2025-12
Karyopharm Therapeutics USD 264.49M 13.73M 2026-03